NexImmune (NEXI) Stock Chart & Stock Price History → How to Make 100X on the AI Boom (From InvestorPlace) (Ad) Free NEXI Stock Alerts $3.45 +0.04 (+1.17%) (As of 11:00 AM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media NexImmune Stock Price Performance5 Day Performance-1.45%1 Month Performance-5.54%3 Month Performance-61.94%6 Month Performance+20.92%Year-To-Date Performance+53.60%1 Year Performance-51.30% Receive NEXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide NEXI Stock Chart for Tuesday, May, 14, 2024 NEXI Chart by TradingView NexImmune Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$3.60$3.41-5.28%$3.56$3.398,817 shs$4.67 million05/10/2024$3.46$3.60+4.05%$3.60$3.425,526 shs$4.93 million05/09/2024$3.49$3.46-0.86%$3.84$3.3640,839 shs$4.74 million05/08/2024$3.59$3.49-2.79%$3.71$3.3223,466 shs$4.78 million05/07/2024$3.52$3.59+1.99%$3.80$3.2271,616 shs$4.92 million05/06/2024$3.32$3.52+6.02%$3.52$3.3010,295 shs$4.83 million Get the Latest News and Ratings for NEXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$3.12$3.32+6.41%$3.49$3.1037,409 shs$4.55 million05/02/2024$3.29$3.12-5.17%$3.20$3.0714,099 shs$4.27 million05/01/2024$3.36$3.29-2.08%$3.36$3.1510,517 shs$4.51 million04/30/2024$3.28$3.36+2.44%$3.38$3.283,229 shs$4.60 million04/29/2024$3.37$3.28-2.67%$3.42$3.2415,681 shs$4.49 million04/26/2024$3.41$3.41$3.47$3.373,391 shs$4.67 million04/25/2024$3.26$3.41+4.60%$3.59$3.267,330 shs$4.67 million04/24/2024$3.43$3.26-4.96%$3.48$3.2612,693 shs$4.47 million04/23/2024$3.65$3.43-5.90%$3.59$3.436,761 shs$4.70 million04/22/2024$3.49$3.65+4.44%$3.89$3.4044,839 shs$5.00 million04/19/2024$3.29$3.36+2.13%$3.50$3.0622,854 shs$4.60 million04/18/2024$3.15$3.29+4.44%$3.34$3.176,901 shs$3.49 million04/17/2024$3.47$3.15-9.22%$3.43$3.0133,599 shs$3.34 million04/16/2024$3.55$3.47-2.25%$3.62$3.449,176 shs$3.68 million04/15/2024$3.61$3.55-1.66%$3.85$3.4226,886 shs$3.76 million04/12/2024$3.94$3.61-8.38%$4.00$3.5722,028 shs$3.83 million04/11/2024$3.96$3.94-0.38%$4.05$3.7926,842 shs$4.18 million04/10/2024$3.62$3.96+9.25%$4.10$3.6585,919 shs$4.19 million04/09/2024$4.30$3.62-15.81%$4.42$3.6265,987 shs$3.84 million04/08/2024$3.71$4.30+15.90%$4.35$3.56207,641 shs$4.55 million04/05/2024$4.58$3.71-19.00%$4.94$3.6986,305 shs$3.93 million04/04/2024$5.05$4.58-9.31%$5.09$4.5619,688 shs$4.86 million04/03/2024$5.36$5.05-5.78%$5.38$5.0316,601 shs$5.35 million04/02/2024$5.58$5.36-3.94%$5.70$5.2913,708 shs$5.68 million04/01/2024$5.61$5.58-0.53%$5.72$5.5010,571 shs$5.92 million03/29/2024$5.61$5.61$5.70$5.5112,553 shs$5.95 million03/28/2024$5.51$5.61+1.81%$5.70$5.5112,192 shs$5.94 million03/27/2024$5.69$5.51-3.16%$5.75$5.5117,565 shs$5.84 million03/26/2024$5.75$5.69-1.04%$5.80$5.6519,092 shs$6.03 million03/25/2024$5.64$5.75+1.95%$5.91$5.6314,258 shs$6.10 million03/22/2024$5.87$5.64-3.92%$5.86$5.6216,775 shs$5.98 million03/21/2024$5.72$5.87+2.62%$5.90$5.7020,083 shs$6.22 million03/20/2024$5.76$5.72-0.69%$6.00$5.5734,739 shs$6.06 million03/19/2024$5.60$5.76+2.86%$6.00$5.54144,340 shs$6.11 millionGuard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. 03/18/2024$5.79$5.60-3.28%$6.08$5.5176,266 shs$5.94 million03/15/2024$6.05$5.79-4.30%$6.23$5.7930,726 shs$6.14 million03/14/2024$6.09$6.05-0.66%$6.15$5.7849,550 shs$6.40 million03/13/2024$5.88$6.09+3.57%$6.17$5.8843,308 shs$6.46 million03/12/2024$5.96$5.88-1.34%$5.98$5.7544,049 shs$6.23 million03/11/2024$6.00$5.96-0.67%$6.13$5.6746,533 shs$6.32 million03/08/2024$6.30$6.00-4.76%$6.50$5.8687,613 shs$6.36 million03/07/2024$6.53$6.30-3.52%$9.40$6.26769,073 shs$6.68 million03/06/2024$6.50$6.53+0.46%$6.63$5.88155,622 shs$6.92 million03/05/2024$5.97$6.50+8.88%$6.57$5.76159,668 shs$6.89 million03/04/2024$6.19$5.97-3.55%$6.58$5.9458,588 shs$6.32 million03/01/2024$6.70$6.19-7.61%$6.69$6.1967,950 shs$6.56 million02/29/2024$6.78$6.70-1.18%$7.36$6.5572,708 shs$7.09 million02/28/2024$6.99$6.78-3.00%$7.27$6.7238,955 shs$7.19 million02/27/2024$7.08$6.99-1.27%$7.73$6.9266,125 shs$7.41 million02/26/2024$6.76$7.08+4.73%$7.31$6.7083,619 shs$7.51 million02/23/2024$7.18$6.76-5.85%$7.22$6.7033,600 shs$7.17 million02/22/2024$7.86$7.18-8.65%$7.86$6.9274,666 shs$7.61 million02/21/2024$8.56$7.86-8.18%$8.35$7.7666,457 shs$8.33 million02/20/2024$7.78$8.56+10.03%$9.80$7.78464,712 shs$9.07 million02/19/2024$7.78$7.78$8.30$7.6977,100 shs$8.23 million02/16/2024$8.44$7.78-7.82%$8.30$7.6976,408 shs$8.25 million02/15/2024$8.96$8.44-5.80%$9.11$8.1952,713 shs$8.93 million02/14/2024$9.02$8.96-0.67%$9.55$8.8846,526 shs$9.50 million02/13/2024$9.94$9.02-9.26%$10.00$8.85102,164 shs$9.56 million Related Companies: Seelos Therapeutics Stock Chart ZyVersa Therapeutics Stock Chart Kazia Therapeutics Stock Chart Synaptogenix Stock Chart Petros Pharmaceuticals Stock Chart Bright Minds Biosciences Stock Chart China Pharma Stock Chart Lipella Pharmaceuticals Stock Chart Genprex Stock Chart First Wave BioPharma Stock Chart Receive NEXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NEXI) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.